Cardiovascular effects of melanocortins
Open accessAbstract
Melanocortins (MSH's) are three structurally related peptides derived from proopiomelanocortin. They regulate several physiologic functions including energy metabolism, appetite, and inflammation. Recent work in rodents has also identified important effects of MSH's, particularly γ-MSH, on sodium metabolism and blood pressure regulation. Normal rats and mice respond to a high sodium diet with an increase in the plasma concentration of γ-MSH, and remain normotensive, while those with genetic or pharmacologic γ-MSH deficiency become hypertensive on a high sodium diet. This hypertension is corrected by exogenous administration of the peptide. Mice lacking the γ-MSH receptor (the melanocortin 3 receptor, Mc3r) also become hypertensive on a high sodium diet but remain so when administered γ-MSH, and infusions of physiologic levels of the peptide stimulate urinary sodium excretion in normal rats and mice, but not in mice with deletion of Mc3r. The salt-sensitive hypertension in rodents with impaired γ-MSH signaling appears due to stimulation of noradrenergic activity, since plasma noradrenaline is increased and the hypertension is rapidly corrected with infusion of the α-adrenoceptor antagonist phentolamine. In contrast to the antihypertensive property of physiologic levels of γ-MSH, intravenous or intracerebroventricular injections of high levels of the peptide raise blood pressure. This occurs in mice lacking Mc3r, indicating an interaction with some other central receptor. Finally, the salt-sensitive hypertension in rodents with disruption of γ-MSH signaling is accompanied by insulin resistance, an observation which offers a new window into the study of the association of salt-sensitive hypertension with insulin resistance and type II diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
γ-MSH has pro-hypertensive as well as antihypertensive actions.
“Previous studies have suggested that γ-MSH has pro-hypertensive as well as antihypertensive actions [15].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [15]
Injections of γ-MSH intravenously or intracerebroventricularly raise blood pressure and heart rate.
“Injections of γ-MSH (i.v. or ICV) have been reported to raise BP and HR, although injections into the NTS lower BP and HR [15].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [15]
γ-MSH-induced natriuresis appears to be mediated primarily by activation of MC3R and subsequent stimulation of cAMP production in the kidney.
“Although the physiological significance of γ-MSH-induced natriuresis has not been fully elucidated, the effect appears to be mediated primarily by activation of MC3R and subsequent stimulation of cAMP production in the kidney [15].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [15]
Injections of γ-MSH into the nucleus tractus solitarius lower blood pressure and heart rate.
“Injections of γ-MSH (i.v. or ICV) have been reported to raise BP and HR, although injections into the NTS lower BP and HR [15].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [15]
γ-MSH has natriuretic effects when infused directly into the renal artery.
“Several studies have demonstrated that γ-MSH also has natriuretic effects when infused directly into the renal artery [15, 20].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · see citing works
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344 · see citing works
Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor
Nakanishi, S., Inoue, A., Kita, T., Inoue, A., Nakamura, M., Chang, A. C. Y., Cohen, S. N., & Numa, S. (1979) · Nature · doi:10.1038/278423a0 · Cited by 1,760 · see citing works
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435 · see citing works
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216 · see citing works
Neural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212 · see citing works
Neural Control of Renal Function*
Kopp, U. C., & DiBona, G. F. (2020) · Reflex Control of the Circulation · doi:10.1201/9780367813338-17 · Cited by 1,126 · see citing works
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
DeFronzo, R. A., Cooke, C. R., Andres, R., Faloona, G. R., & Davis, P. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107996 · Cited by 1,113 · see citing works
Structure of a Molluscan Cardioexcitatory Neuropeptide
Price, D. A., & Greenberg, M. J. (1977) · Science · doi:10.1126/science.877582 · Cited by 1,064 · see citing works
Blood Pressure Control—Special Role of the Kidneys and Body Fluids
Guyton, A. C. (1991) · Science · doi:10.1126/science.2063193 · Cited by 972 · see citing works
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930 · see citing works
Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X.-M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., et al. (2000) · Nature Genetics · doi:10.1038/79254 · Cited by 896 · see citing works
A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse
Butler, A. A., Kesteson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., DeKoning, J., Baetscher, M., & Cone, R. D. (2000) · Endocrinology · doi:10.1210/endo.141.9.7791 · Cited by 703 · see citing works
Proopiomelanocortin Processing in the Pituitary, Central Nervous System, and Peripheral Tissues
Smith, A. I., & Funder, J. W. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-159 · Cited by 539 · see citing works
Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.342 · Cited by 533 · see citing works
Chen, W., Kelly, M. A., Opitz-Araya, X., Thomas, R. E., Low, M. J., & Cone, R. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80467-5 · Cited by 488 · see citing works
Proteolytic Processing in the Secretory Pathway
Zhou, A., Webb, G. C., Zhu, X., & Steiner, D. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20745 · Cited by 457 · see citing works
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2
Furuta, M., Yano, H., Zhou, A., Rouillé, Y., Holst, J. J., Carroll, R., Ravazzola, M., Orci, L., Furuta, H., & Steiner, D. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6646 · Cited by 430 · see citing works
Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel
Lingueglia, É., Champigny, G., Lazdunski, M., & Barbry, P. (1995) · Nature · doi:10.1038/378730a0 · Cited by 392 · see citing works
New aspects on the melanocortins and their receptors
Wikberg, J. E. S., Muceniece, R., Mandrika, I., Prūsis, P., Lindblom, J., Post, C., & Skottner, A. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0725 · Cited by 318 · see citing works
Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary
Day, R. W., Schäfer, M., Watson, S. J., Chrétien, M., & Seidah, N. G. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.3.1316544 · Cited by 268 · see citing works
Zhou, A., Bloomquist, B. T., & Mains, R. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53918-1 · Cited by 262 · see citing works
Insulin stimulates volume absorption in the rabbit proximal convoluted tubule.
Baum, M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112925 · Cited by 248 · see citing works
Bromocriptine: a novel approach to the treatment of type 2 diabetes.
Pijl, H., Ohashi, S., Matsuda, M., Miyazaki, Y., Mahankali, A., Kumar, V., Pipek, R., Iozzo, P., Lancaster, J. L., Cincotta, A. H., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1154 · Cited by 238 · see citing works
Gaziano, J. M., Cincotta, A. H., O’Connor, C. M., Ezrokhi, M., Rutty, D., Ma, Z., & Scranton, R. E. (2010) · Diabetes Care · doi:10.2337/dc09-2009 · Cited by 214 · see citing works
The melanocortin system and energy balance
Butler, A. A. (2006) · Peptides · doi:10.1016/j.peptides.2005.02.029 · Cited by 196 · see citing works
Furuta, M., Carroll, R., Martin, S., Swift, H. H., Ravazzola, M., Orci, L., & Steiner, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3431 · Cited by 187 · see citing works
Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice
Furuta, M., Zhou, A., Webb, G. C., Carroll, R., Ravazzola, M., Orci, L., & Steiner, D. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103362200 · Cited by 164 · see citing works
Strauss, M. B. (1958) · A M A Archives of Internal Medicine · doi:10.1001/archinte.1958.00260210013003 · Cited by 161 · see citing works
Li, S.-J., Varga, K., Archer, P., Hruby, V. J., Sharma, S. D., Kesterson, R. A., Cone, R. D., & Kunos, G. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05182.1996 · Cited by 152 · see citing works
Ellacott, K. L. J., & Cone, R. D. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1861 · Cited by 134 · see citing works
Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity
Muntzel, M. S., Morgan, D. A., Mark, A. L., & Johnson, A. K. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.267.5.r1350 · Cited by 134 · see citing works
Hormonal Regulation Of POMC Gene Expression
Autelitano, D. J. (1989) · Annual Review of Physiology · doi:10.1146/annurev.physiol.51.1.715 · Cited by 130 · see citing works
Hormonal Regulation of POMC Gene Expression
Autelitano, D. J., Lundblud, J. R., Blum, M., & Roberts, J. L. (1989) · Annual Review of Physiology · doi:10.1146/annurev.ph.51.030189.003435 · Cited by 117 · see citing works
The physiological role of melanocortin receptors
Schiöth, H. B. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)63007-3 · Cited by 110 · see citing works
Vasopressin in Circulatory Control and Hypertension
Johnston, C. I. (1985) · Journal of Hypertension · doi:10.1097/00004872-198512000-00001 · Cited by 109 · see citing works
Lingueglia, É., Deval, E., & Lazdunski, M. (2006) · Peptides · doi:10.1016/j.peptides.2005.06.037 · Cited by 109 · see citing works
Kok, P., Roelfsema, F., Frölich, M., PELT, J. V., Stokkel, M. P. M., Meinders, A. E., & Pijl, H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00567.2005 · Cited by 107 · see citing works
Luo, S., Liang, Y. T., & Cincotta, A. H. (1999) · Neuroendocrinology · doi:10.1159/000054415 · Cited by 89 · see citing works
Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones
Ni, X.-P., Butler, A. A., Cone, R. D., & Humphreys, M. H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249702.49854.fa · Cited by 88 · see citing works
Defective Prodynorphin Processing in Mice Lacking Prohormone Convertase PC2
Berman, Y. L., Mzhavia, N., Polonskaia, A., Furuta, M., Steiner, D. F., Pintar, J. E., & Devi, L. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751763.x · Cited by 87 · see citing works
Adams, J. M., Madden, C. J., Sved, A. F., & Stocker, S. D. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091843 · Cited by 82 · see citing works
Melanocortin 3 receptors control crystal‐induced inflammation
Getting, S. J., Lam, C. W., Chen, A. S., Grieco, P., & Perretti, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6339com · Cited by 74 · see citing works
Ni, X.-P., Pearce, D., Butler, A. A., Cone, R. D., & Humphreys, M. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316993 · Cited by 74 · see citing works
Ni, X.-P., Pearce, D., Butler, A. A., Cone, R. D., & Humphreys, M. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16993 · Cited by 73 · see citing works
Gruber, K. A., & Callahan, M. F. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.257.4.r681 · Cited by 70 · see citing works
Allen, R. G., Peng, B. W., Pellegrino, M. J., Miller, E. D., Grandy, D. K., Lundblad, J. R., Washburn, C. L., & Pintar, J. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05864.2001 · Cited by 68 · see citing works
Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential Hypertension
Sowers, J. R. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-6-1133 · Cited by 67 · see citing works
Prolactin, a natriuretic hormone, interacting with the renal dopamine system
Ibarra, F. R., Crambert, S., Eklöf, A., Lundquist, A., Hansell, P., & Holtbäck, U. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00586.x · Cited by 55 · see citing works
Insulin resistance and salt-sensitive hypertension in metabolic syndrome
Fujita, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm409 · Cited by 51 · see citing works
γ-MSH, sodium metabolism, and salt-sensitive hypertension
Humphreys, M. H. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00365.2003 · Cited by 51 · see citing works
Self-citationBromocriptine stimulates Na+,K+-ATPase in renal proximal tubules via the cAMP pathway
Hussain, T., Abdul-Wahab, R., & Lokhandwala, M. F. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00039-3 · Cited by 50 · see citing works
Matsumura, K., Tsuchihashi, T., Abe, I., & Iida, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03045-7 · Cited by 49 · see citing works
Natrriuresis produced by vasopressin or hemorrhage during water diuresis in the dog
Mh, H., Rm, F., & Earley, L. E. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.3.658 · Cited by 47 · see citing works
Lin, S., Chaves, C., Wiedemann, E., & Humphreys, M. H. (1987) · Hypertension · doi:10.1161/01.hyp.10.6.619 · Cited by 46 · see citing works
Carey, R. M., LOON, V. R., Baines, A. D., & Kaiser, D. L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-3-595 · Cited by 43 · see citing works
Dopaminergic Regulation of Secretory Granule‐Associated Proteins in Rat Intermediate Pituitary
Oyarce, A. M., Hand, T. A., Mains, R. E., & Eipper, B. A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010229.x · Cited by 41 · see citing works
Cardiovascular effects of γ-MSH/ACTH-like peptides: structure-activity relationship
Van Bergen, P., Janssen, P. M. L., Hoogerhout, P., De Wildt, D. J., & Versteeg, D. H. G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00657-5 · Cited by 40 · see citing works
Huang, B. S., & Leenen, F. H. H. (2002) · Hypertension · doi:10.1161/hy02t2.103004 · Cited by 39 · see citing works
Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Nagahama, S., Chen, Y. F., & Oparil, S. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21708-6 · Cited by 39 · see citing works
Mannelli, M., Delitala, G., FEO, L. M. D., Maggi, M., Cuomo, S., Piazzini, M., Guazzelli, R., & Serio, M. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-74 · Cited by 37 · see citing works
GAMMA–2 MSH IS NATRIURETIC IN THE RAT
Lymangrover, J. R., Buckalew, V. M., Harris, J., KLEIN, M. C., & Gruber, K. A. (1985) · Endocrinology · doi:10.1210/endo-116-3-1227 · Cited by 34 · see citing works
Hill, C., & Dunbar, J. C. (2002) · Peptides · doi:10.1016/s0196-9781(02)00103-1 · Cited by 34 · see citing works
Ni, X.-P., Bhargava, A., Pearce, D., & Humphreys, M. H. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00279.2005 · Cited by 34 · see citing works
Wildt, D. J. D., Ven, J. C. V. D., Bergen, P. V., Lang, H. D., & Versteeg, D. H. G. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178205 · Cited by 31 · see citing works
Role of FMRFamide-Activated Brain Sodium Channel in Salt-Sensitive Hypertension
Nishimura, M., Ohtsuka, K., Takahashi, H., & Yoshimura, M. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.443 · Cited by 30 · see citing works
Centrally Mediated Effects of Bromocriptine on Cardiac Sympathovagal Balance
Franchi, F., Lazzeri, C., Barletta, G., Ianni, L., & Mannelli, M. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.123 · Cited by 29 · see citing works
Ni, X.-P., Kesterson, R. A., Sharma, S. D., Hruby, V. J., Cone, R. D., Wiedemann, E., & Humphreys, M. H. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r931 · Cited by 27 · see citing works
Dietary Sodium Intake Modulates Pituitary Proopiomelanocortin mRNA Abundance
Mayan, H., Ling, K. T., Lee, E. Y., Wiedemann, E., Kalinyak, J. E., & Humphreys, M. H. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.244 · Cited by 26 · see citing works
Mechanism of the natriuretic action of gamma-melanocyte-stimulating hormone
Chen, X. W., Ying, W., Valentin, J., Ling, K. T., Lin, S., Wiedemann, E., & Humphreys, M. H. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.6.r1946 · Cited by 25 · see citing works
Design, Synthesis and Biological Evaluation of Ligands Selective for the Melanocortin-3 Receptor
Hruby, V. J., Cai, M., Cain, J. P., Mayorov, A. V., Dedek, M. M., & Trivedi, D. B. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906645 · Cited by 25 · see citing works
Effects of bromocriptine on single nephron and whole-kidney function in rats.
Stier, C. T., Cowden, E. A., & Allison, M. E. M. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32947-2 · Cited by 25 · see citing works
Bergen, P. V., Kleijne, J., Wildt, D. J. D., & Versteeg, D. H. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701065 · Cited by 24 · see citing works
Nijsen, M. J. M. A., De Ruiter, G. J. W., Kasbergen, C. M., Hoogerhout, P., & De Wildt, D. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703709 · Cited by 24 · see citing works
Carter, D., Pardy, K., & Murphy, D. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00712991 · Cited by 22 · see citing works
Kinetics of sodium homeostasis in rats: rapid excretion and equilibration rates
Holtzman, E. J., Braley, L. M., Williams, G. H., & Hollenberg, N. K. (1988) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1988.254.6.r1001 · Cited by 21 · see citing works
Chandramohan, G., Durham, N., Sinha, S. K., Norris, K. C., & Vaziri, N. D. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.022 · Cited by 19 · see citing works
Bergen, P. V., Vaart, J. G. M. V. D., Kasbergen, C. M., Versteeg, D. H. G., & Wildt, D. J. D. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00806-0 · Cited by 16 · see citing works
Cardiovascular Mechanisms of Gamma (γ)2-MSH
Callahan, M. F., Kirby, R. F., Lymangrover, J. R., Johnson, A. K., & Gruber, K. A. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409046067 · Cited by 16 · see citing works
Mayan, H., Ni, X.-P., Almog, S., & Humphreys, M. H. (2003) · Hypertension · doi:10.1161/01.hyp.0000097601.83235.f8 · Cited by 14 · see citing works
Chandramohan, G., Ni, X.-P., Kalinyak, J. E., & Humphreys, M. H. (2001) · Pituitary · doi:10.1023/a:1020746414046 · Cited by 13 · see citing works
NOVEL NEURAL PATHWAYS OF CARDIOVASCULAR CONTROL BY α‐ AND γ‐MSH
Kunos, G., Li, S., Varga, K., Archer, P., Kesterson, R., Cone, R. D., Hruby, V., & Sharma, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00874.x · Cited by 13 · see citing works
van den Buuse, M., & Lambrechts, A. C. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06549.x · Cited by 12 · see citing works
Isogai, O., Tsukamoto, K., Masubuchi, Y., Tomioka, S., Suzuki, T., Kawato, H., Yajima, Y., Kasamaki, Y., Ito, S., & Kanmatsuse, K. (2005) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200044252 · Cited by 10 · see citing works
Hao, J., & Rabkin, S. W. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y96-064 · Cited by 10 · see citing works
OGURO, M., Takeda, K., Itoh, H., Takesako, T., TANAKA, M., Takenaka, K., Hirata, M., Nakata, T., TANABE, S., Hayashi, J., et al. (1992) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.56.943 · Cited by 10 · see citing works
Muntzel, M. S., Crespo, R., Joseph, T., & Onwumere, O. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.020 · Cited by 10 · see citing works
Prevention of Salt-Induced Hypertension by an Analog of γ-Melanocyte-Stimulating Hormone in the Rat
NI, X., & Humphreys, M. H. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.014 · Cited by 9 · see citing works
Sagnella, G. A., Markandu, N. D., Singer, D. R. J., & MacGregor, G. A. (1990) · Clinical and Experimental Hypertension · doi:10.3109/10641969009074726 · Cited by 8 · see citing works
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat
Nagahama, S., Chen, Y.-F., & Oparil, S. (1985) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1985.249.1.h64 · Cited by 8 · see citing works
Salt-sensitive hypertension: if only it were as simple as rocket science
Reudelhuber, T. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18397 · Cited by 7 · see citing works
Racz, K., Kuchel, O., & Buu, N. T. (1986) · PubMed · Cited by 7 · see citing works
Ni, X.-P., & Humphreys, M. H. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.290 · Cited by 6 · see citing works
Kanayama, Y., Kohno, M., Takaori, K., Itoh, S., Yasunari, K., & Takeda, T. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb00969.x · Cited by 6 · see citing works
Bealer, S. L., & Metcalf, C. S. (2004) · Autonomic Neuroscience · doi:10.1016/j.autneu.2004.10.005 · Cited by 4 · see citing works
Ni, X.-P., van Dijk, C. M. A., Pearce, D., & Humphreys, M. H. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2009.046748 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Neural melanocortin receptors in obesity and related metabolic disorders
Girardet, C., & Butler, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.004 · Cited by 128 · see citing works
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
Sharma, S., Garfield, A., Shah, B. P., Kleyn, P., Ichetovkin, I., Moeller, I., Mowrey, W. R., & van der Ploeg, L. (2019) · Molecules · doi:10.3390/molecules24101892 · Cited by 53 · see citing works
Begriche, K., Levasseur, P. R., Zhang, J., Rossi, J., Skorupa, D., Solt, L. A., Young, B. M., Burris, T. P., Marks, D. L., Mynatt, R. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278374 · Cited by 61 · see citing works
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
Gonçalves, J. P. L., Palmer, D., & Meldal, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.004 · Cited by 55 · see citing works
Jiang, P., Ma, D., Wang, X., Wang, Y., Bi, Y., Jl, Y., Wang, X., & Li, X. (2018) · PubMed Central · doi:10.14348/molcells.2018.2156 · Cited by 54 · see citing works
Approach to assessing determinants of glucose homeostasis in the conscious mouse
Hughey, C. C., Wasserman, D. H., Lee, R. S., & Lantier, L. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9533-z · Cited by 50 · see citing works
The Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47 · see citing works
Role of the brain melanocortins in blood pressure regulation
do Carmo, J. M., da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Perez de Lara, C. E., & Hall, J. E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.003 · Cited by 38 · see citing works
Enkephalins and ACTH in the mammalian nervous system
Duque-Díaz, E., Ojeda, O. M. Á., & Coveñas, R. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.05.001 · Cited by 26 · see citing works
Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia
do Carmo, J. M., da Silva, A. A., Moak, S. P., da Silva, F. S., Spradley, F. T., & Hall, J. E. (2018) · Acta Physiologica · doi:10.1111/apha.13222 · Cited by 14 · see citing works
Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice
Rinne, P., Tikka, S., Mäkelä, S., Streng, T., & Savontaus, E. (2012) · Peptides · doi:10.1016/j.peptides.2012.09.004 · Cited by 14 · see citing works
da Silva, A. A., Freeman, J. N., Hall, J. E., & do Carmo, J. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00293.2017 · Cited by 11 · see citing works
The brain splits obesity and hypertension
Humphreys, M. H. (2011) · Nature Medicine · doi:10.1038/nm0711-782 · Cited by 12 · see citing works
van den Buuse, M., & Lambrechts, A. C. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06549.x · Cited by 12 · see citing works
Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs
Axiak‐Bechtel, S. M., Leach, S. B., Scholten, D. G., Newton‐Northup, J., Johnson, B. J., Durham, H. E., Gruber, K. A., & Callahan, M. F. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.777 · Cited by 9 · see citing works
Pharmacology of the giant panda (Ailuropoda melanoleuca) melanocortin-3 receptor
Zhang, H.-J., Xie, H., Wang, W., Wang, Z., & Tao, Y. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.10.024 · Cited by 10 · see citing works
Role of the Melanocortin System in the Central Regulation of Cardiovascular Functions
Copperi, F., Kim, J. D., & Diano, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.725709 · Cited by 9 · see citing works
Safety of TCMCB07, a melanocortin-4 antagonist peptide, in dogs with naturally occurring cachexia
Axiak‐Bechtel, S. M., Leach, S. B., Newton‐Northup, J., Milner, R. J., Fox‐Alvarez, S. A., Fagman, L. I., Young, K. A., Tate, D. J., Wright, Z. M., Chretin, J. D., et al. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16915 · Cited by 5 · see citing works
Structural determinants regulating cell surface targeting of melanocortin receptors
Rodrigues, A. R., Sousa, D., Almeida, H., & Gouveia, A. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0055 · Cited by 7 · see citing works
do Carmo, J. M., da Silva, A. A., Moak, S. P., Houghton, H. J., Smith, A. D., & Hall, J. E. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv182 · Cited by 4 · see citing works
Hypertension in obesity: the role of hypothalamic inflammation
Shin, J. I., & Cai, D. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44-c1 · Cited by 4 · see citing works
Prindle, C. R., Bennett, T. L., Rajewski, B. H., Kelley, K. J., Impastato, A. C., Potterfield, R., Marks, D. L., & Delev, J. Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797586 · Cited by 3 · see citing works
Jégou, S., Cone, R. D., Eberlé, A. N., & Vaudry, H. (2013) · Handbook of Biologically Active Peptides · doi:10.1016/b978-0-12-385095-9.00111-1 · Cited by 2 · see citing works
Shpakov, A. O., Derkach, K. V., Жарова, О. А., Shpakova, E. A., & Бондарева, В. М. (2015) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747815010079 · Cited by 2 · see citing works
Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Hall, J. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Wang, Z., & Hall, M. E. (2026) · Clinical Science · doi:10.1042/cs20250039
- Authors
- Humphreys, M. H., Ni, X.-P., & Pearce, D.
- Affiliations
- San Francisco General Hospital (US)
- Corresponding author
- Humphreys, Michael H.
- ORCID
- Pearce, David
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 660
- Issue
- 1
- Pages
- 43-52
- ISSN
- 0014-2999 (ISSN-L)
- PMC
- PMC3086937
- OpenAlex
- W2090422970
- Cited by
- 25
- References
- 96
- Citations by year
- 2026: 2 · 2023: 1 · 2021: 2 · 2019: 2 · 2018: 5 · 2017: 1 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL068871, HL 68871)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- melanocortin peptides, gamma-MSH, proopiomelanocortin, melanocortin 3 receptor, salt-sensitive hypertension, high-salt diet, sodium metabolism, blood pressure regulation, sodium excretion, norepinephrine, alpha-adrenoceptor antagonism, phentolamine, insulin resistance, type 2 diabetes, cardiovascular effects
- MeSH terms
- Animals, Blood Pressure, Cardiovascular System, Glucose, Humans, Signal Transduction, gamma-MSH, Melanocortins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review